Discontinuation report M-EZETIMIBE

Last updated on 2020-04-08 History
Report ID 108914
Drug Identification Number 02467437
Brand name M-EZETIMIBE
Common or Proper name Ezetimibe
Company Name MANTRA PHARMA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) EZETIMIBE
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C10AX
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for discontinuation Other (Please describe in comments)
Anticipated discontinuation date 2020-04-01
Actual discontinuation date 2020-04-07
Remaining supply date 2020-04-01
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Switch to another format (blister of 30 tablets)
Health Canada comments
Contact Address 9150, BOUL. LEDUC, SUITE 201
BROSSARD, QUEBEC
CANADA J4Y 0E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-04-08 French Compare
v5 2020-04-07 French Compare
v4 2020-04-07 English Compare
v3 2020-04-07 English Compare
v2 2020-03-18 French Compare
v1 2020-03-18 English Compare